Received Mar 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 79MR9 | — |
patient have received only the diluent portion of Shingrix; patient have received only the diluent portion of Shingrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 66-year-old male patient who received Herpes zoster (Shingrix) (batch number 79MR9, expiry date 26-AUG-2027) for prophylaxis. On 11-FEB-2026, the patient received Shingrix. On 11-FEB-2026, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient have received only the diluent portion of Shingrix) and inappropriate dose of vaccine administered (Verbatim: patient have received only the diluent portion of Shingrix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 10-MAR-2026 The patient had received only the diluent portion of Shingrix and wanted to know how to proceed. This was 1 of 3 linked cases, reported by the same reporter.; Sender's Comments: US-GSK-US2026033729:Same reporter/Different patient US-GSK-US2026033733:Same reporter/Different patient